Mitä "Tyhjennä" tarkoittaa?
Eläin ei kanna mutaatiota. Se ei kehitä tautia eikä anna sitä eteenpäin.
Koira Suulakihalkio, versio 2 (CP2)
The DNA test for Cleft Palate Variant 2 (CP2) in dogs is a crucial tool for breeders aiming to reduce the risk of this genetic disorder. CP2 is a hereditary condition that causes cleft palate, leading to feeding difficulties and respiratory issues in affected puppies. By identifying carriers through genetic testing, breeders can make informed mating decisions to prevent passing the mutation to offspring. This test is simple, accurate, and essential for maintaining healthy dog populations. Early detection of CP2 helps improve puppy survival rates and overall breed health. Investing in the CP2 DNA test supports responsible breeding practices and promotes the well-being of future generations. Ensure your breeding program includes CP2 screening to safeguard your dogs’ health.
Lyhenne: CP2
Analysoitu mutaatio: ADAMTS20 c.1358_1359del
Perintö: Autosomaalinen resessiivinen
Lyhenne
CP2
Havaittu taajuus
Kliininen vakavuus
Kliininen luokitus
Kehityshäiriöt
Analysoitu mutaatio
ADAMTS20 c.1358_1359del
p.(K453Ifs*4)
p.(K453Ifs*4)
Periytymistapa
Autosomaalinen resessiivinen
Testin yhteenveto:
The DNA test for Cleft Palate Variant 2 (CP2) in dogs helps identify genetic mutations linked to this congenital condition. CP2 causes an opening in the roof of the mouth, which can lead to feeding difficulties and respiratory issues. Early detection through genetic screening allows breeders to make informed decisions and reduce the risk of passing the trait to offspring. This test is especially important in breeds prone to cleft palate disorders. Overall, CP2 testing supports healthier breeding practices and improves puppy welfare.
Saatavilla pakkauksesta: Basic
Tämä DNA-testi sisältyy pakettiin alkaen Basic — ja se on myös osa paketteja Basic, Standard, Advanced, Complete.
Katso DNA-testipaketit →Valitse pakkaus, joka sopii parhaiten eläinten jalostukseen tai terveysstrategiaan.
Understanding Cleft Palate Variant 2 (CP2) in Dogs
Cleft Palate Variant 2 (CP2) is a genetic condition that affects the development of the palate in dogs. This condition is characterized by a failure of the hard and/or soft palate to fuse properly during embryonic development, resulting in an abnormal opening that can lead to various health complications. CP2 can significantly impact the quality of life for affected dogs, making early detection and management crucial.
Clinical Manifestations of CP2
Dogs with Cleft Palate Variant 2 may exhibit a range of clinical signs. Common symptoms include difficulty in feeding, nasal discharge, and an increased risk of aspiration pneumonia due to food or liquid entering the respiratory tract. Puppies with CP2 may struggle to gain weight and thrive, and they may require special feeding techniques or interventions to ensure adequate nutrition.
Genetic Basis of CP2
The genetic basis of Cleft Palate Variant 2 is linked to specific mutations that disrupt normal palatine development. Understanding the genetic factors associated with CP2 can help breeders make informed decisions when selecting breeding pairs, ultimately reducing the prevalence of this condition in future generations. The identification of these genetic markers is essential for advancing research and improving breeding practices.
Hoito- ja hoitovaihtoehdot
Managing Cleft Palate Variant 2 often requires a multidisciplinary approach involving veterinarians, veterinary surgeons, and pet owners. Surgical intervention may be necessary to close the cleft and improve the dog's quality of life. In addition to surgical repair, affected dogs may need ongoing care, such as dietary modifications and regular veterinary check-ups, to monitor for potential complications.
Geneettisen testauksen merkitys
Genetic testing for Cleft Palate Variant 2 is a valuable tool for breeders and pet owners. By identifying carriers of the CP2 gene, breeders can make more informed decisions to minimize the risk of producing affected puppies. Moreover, genetic testing can provide peace of mind for pet owners, allowing them to understand their dog's health status and take proactive measures if necessary.
Johtopäätös
Cleft Palate Variant 2 (CP2) is a significant genetic condition that affects the oral and respiratory health of dogs. Through early detection, effective management, and responsible breeding practices informed by genetic testing, the impact of CP2 can be mitigated. Ongoing research into the genetic underpinnings of this condition will further enhance our understanding and ability to address it in canine populations.
Testissä tunnustettu rotu: Suulakihalkio, versio 2 (CP2)
- Nova Scotia Duck Tolling Retriever
🧬 Interpretation of genotypes CP2
Genotyyppi
Status
🟡 N/N
Ei liikenteenharjoittaja - Ei riskiä
🟡 N/CP2
Kuljetin - Ei riskiä
❌ CP2/CP2
Vaikutus – vaarassa
FAQ: tulkinnan ymmärtäminen
Onko "Kantaja" tosissaan?
Ei. Eläin on yleensä terve, mutta voi välittää mutaation sen jälkeläisiä.
Entä jos eläin on "vaikuttunut"?
Se sisältää kaksi mutatoitua kopiota. Kliinisiä oireita odotetaan riippuen tauti. Sitä ei pidä kasvattaa.
Miksi miehen/naisen välillä on eroja?
Jotkut sairaudet ovat sukupuoleen liittyviä, joten niiden ilmeneminen vaihtelee riippuen eläimen sukupuoli.
Ennusta jälkeläisiä
N/N (ei-kuljettaja)
N/CP2 (Kuljettaja)
CP2/CP2 (Vaikuttaa)
DNA-testin UKK
Mitä tämä DNA-testi havaitsee?
This DNA test detects the mutation associated with Cleft Palate Variant 2 (CP2) in order to identify clear, carrier, or at-risk animals.
Miksi testata siitoseläintä?
DNA-testaus auttaa kasvattajia suunnittelemaan turvallisempia pariutuksia ja vähentämään mutaation siirtymisen riskiä jälkeläisiin.
Mikä on tämän testin periytymismuoto?
Tässä testissä raportoitu periytymistila on autosomaalinen resessiivinen.
Mitä mutaatiota tässä testissä analysoidaan?
This test analyses the mutation ADAMTS20 c.1358_1359del.
Vaikuttaako kantajaeläimeen välttämättä?
Ei välttämättä. Tulkinta riippuu perinnöllisyysmallista ja tuloksena olevasta genotyypistä.
Viitteet
Wolf Zena T, Brand Harrison A, Shaffer John R, Leslie Elizabeth J, Arzi Boaz, Willet Cali E, Cox Timothy C, McHenry Toby, Narayan Nicole, Feingold Eleanor, Wang Xioajing, Sliskovic Saundra, Karmi Nili, Safra Noa, Sanchez Carla, Deleyiannis Frederic W B, Murray Jeffrey C, Wade Claire M, Marazita Mary L, Bannasch Danika L. Genome-wide association studies in dogs and humans identify ADAMTS20 as a risk variant for cleft lip and palate. PLoS Genet. 2015 Mar 23;11(3):e1005059. doi: 10.1371/journal.pgen.1005059. eCollection 2015 Mar.